EPIX(Delisted)
ESSA PharmaยทNASDAQ
--
--(--)
Is EPIX undervalued or overvalued?
- EPIX scores 0.00/10 on fundamentals and holds a Fair valuation at present. Backed by its -16.20% ROE, 0.00% net margin, 0.00 P/E ratio, 0.00 P/B ratio, and 8.06% earnings growth, these metrics solidify its Neutral investment rating.
